Australian Prescriber

Continuous (interstitial) glucose monitoring is increasingly preferred over capillary (fingerprick) blood glucose monitoring.

As SARS‑CoV‑2 continues to evolve, vaccines are being updated, and policymakers are reviewing the optimal timing of future booster doses to maintain adequate protection against severe illness, particularly for older adults.

Well-designed digital health systems have the potential to improve patient care. Digital health transformation is described in three conceptual ‘horizons’, to enable more efficient ways to deliver care and improve prescribing.

From 2016 Australian medicine names changed to be consistent with International Nonproprietary Names. Dual-ingredient labelling was required for some medicines. This requirement has now ended for most medicines, but will continue for others.